Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
ERII
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
businesswire.com
7 hours ago
seekingalpha.com
10 hours ago
seekingalpha.com
13 hours ago
zacks.com
18 hours ago
seekingalpha.com
21 hours ago
seekingalpha.com
23 hours ago
Earnings Growth
YoY
Current
Estimates
Q3.23
+89%
0.17
vs 0.09
Q4.23
+42%
0.34
vs 0.24
Q1.24
N/A
-0.08
vs -0.08
Q2.24
+400%
0.09
vs -0.03
Q3.24
-12%
0.15
vs 0.17
Q4.24
+47%
0.5
vs 0.34
Q1.25
N/A
-0.13
vs -0.08
Q2.25
-22%
0.07
vs 0.09
Q3.25
-55%
0.07
vs 0.15
Q4.25
+29%
0.65
vs 0.5
Sales Growth
YoY
Current
Estimates
Q3.23
+22%
37M vs 30.5M
Q4.23
+35%
57.2M vs 42.3M
Q1.24
-10%
12.1M vs 13.4M
Q2.24
+31%
27.2M vs 20.7M
Q3.24
+4%
38.6M vs 37M
Q4.24
+17%
67.1M vs 57.2M
Q1.25
-33%
8.1M vs 12.1M
Q2.25
+3%
28.1M vs 27.2M
Q3.25
-22%
29.9M vs 38.6M
Q4.25
+27%
85.2M vs 67.1M
Return on Equity
QoQ
Q1.23
-3%
-0.03
vs 0.07
Q2.23
-1%
-0.01
vs -0.03
Q3.23
+5%
0.05
vs -0.01
Q4.23
+9%
0.09
vs 0.05
Q1.24
-4%
-0.04
vs 0.09
Q2.24
0%
-0.00
vs -0.04
Q3.24
+4%
0.04
vs -0.00
Q4.24
+11%
0.11
vs 0.04
Q1.25
-5%
-0.05
vs 0.11
Q2.25
+1%
0.01
vs -0.05
Institutionnal Ownership
QoQ
Q1.23
177
177
vs 176
1%
Q2.23
187
187
vs 177
6%
Q3.23
183
183
vs 187
-2%
Q4.23
193
193
vs 183
5%
Q1.24
195
195
vs 193
1%
Q2.24
175
175
vs 195
-10%
Q3.24
172
172
vs 175
-2%
Q4.24
190
190
vs 172
10%
Q1.25
204
204
vs 190
7%
Q2.25
177
177
vs 204
-13%
Forecast
2026-Revenue
2026-EPS
2026-EBITDA
Analyst rating
Price Target
0.00(N/A)
Number of analyst
0
Last analyst upgrade/downgrade
CJS Securities
initialisePrevious: Not converted
2025-09-16
Now: Outperform
Seaport Global
initialisePrevious: Not converted
2024-12-05
Now: Buy
Raymond James
upgradePrevious: Outperform
2024-07-09
Now: Strong Buy
Raymond James
upgradePrevious: Not converted
2022-11-08
Now: Outperform
Quote Panel
Key Metrics
Relative Strength
ERII
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|